ライフサイエンスコーパス: orthostatic hypotension

1 One subject had evidence of orthostatic hypotension.

2 eral vascular resistance, often resulting in orthostatic hypotension.

3 ents were peripheral oedema, hypotension, or orthostatic hypotension.

4 oreceptor-cardiac reflex function and causes orthostatic hypotension.

5 m serve to protect against the occurrence of orthostatic hypotension.

6 Five of the LBD cases and all MSA cases had orthostatic hypotension.

7 action can be beneficial in the treatment of orthostatic hypotension.

8 ls, anemia, fatigue, nausea or vomiting, and orthostatic hypotension.

9 tive heart failure, cardiac arrhythmias, and orthostatic hypotension.

10 with standing, in the absence of significant orthostatic hypotension.

11 hort over 4 years; of those who died, 52 had orthostatic hypotension.

12 ious and safe in the treatment of neurogenic orthostatic hypotension.

13 In 9 patients without orthostatic hypotension, 6-[(18)F]fluorodopamine positro

14 It might be possible to improve treatment of orthostatic hypotension acutely with water imbibation an

15 gns of sympathetic neurocirculatory failure (orthostatic hypotension and abnormal blood-pressure resp

16 Screening autonomic function tests indicated orthostatic hypotension and confirmed chronic autonomic

17 ide an explanation for the predisposition to orthostatic hypotension and intolerance in well-trained

18 Orthostatic hypotension and parasympathetic dysfunction

19 Both orthostatic hypotension and postprandial hypotension inc

20 anding than before spaceflight, and in some, orthostatic hypotension and presyncope.

21 betes increases the risk of hypertension and orthostatic hypotension and raises the risk of cardiovas

22 Neurogenic orthostatic hypotension and supine hypertension are comm

23 comes in patients with coexistent neurogenic orthostatic hypotension and supine hypertension, clinici

24 isks for patients with coexistent neurogenic orthostatic hypotension and supine hypertension.

25 erapy in patients with coexistent neurogenic orthostatic hypotension and supine hypertension; and the

26 ration, leading to an increased incidence of orthostatic hypotension and syncope.

27 mediate benefits of treatment for neurogenic orthostatic hypotension and the long-term risks of supin

28 sed a significant increase in heart rate and orthostatic hypotension, and 20% of the nortriptyline-tr

29 imates of impaired BP stabilization, initial orthostatic hypotension, and orthostatic hypotension are

30 c blood pressure (BP) stabilization, initial orthostatic hypotension, and orthostatic hypotension bas

31 re likely to have mild cognitive impairment, orthostatic hypotension, and RBD at baseline, and at pro

32 ients with PD for mild cognitive impairment, orthostatic hypotension, and RBD even at baseline visits

33 to Earth, including inordinate tachycardia, orthostatic hypotension, and uncommonly, syncope.

34 zation, initial orthostatic hypotension, and orthostatic hypotension are reported.

35 zation, initial orthostatic hypotension, and orthostatic hypotension based on beat-to-beat blood pres

36 thesis that short-term alcohol intake causes orthostatic hypotension because of an impairment in the

37 Orthostatic hypotension can reflect altered activity of

38 In Parkinson disease, orthostatic hypotension can result from L-dopa treatment

39 Orthostatic hypotension did not occur in PSP subjects or

40 Orthostatic hypotension did not predict falls after cont

41 Low incidence of orthostatic hypotension has been reported for silodosin,

42 Instead, patients with PD and orthostatic hypotension have clear evidence for barorefl

43 and all with Parkinson's disease-associated orthostatic hypotension, have a loss of cardiac sympathe

44 Orthostatic hypotension in patients with parkinsonism ha

45 Additional options for treatment of orthostatic hypotension include erythropoietin and, surp

46 Orthostatic hypotension is relatively uncommon, may be a

47 In LBD, orthostatic hypotension may be due primarily to involvem

48 Orthostatic hypotension may respond to erythropoietin or

49 The best cluster solution found was based on orthostatic hypotension, mild cognitive impairment, rapi

50 ), urinary tract infections (n=9 [11%]), and orthostatic hypotension (n=8 [10%]).

51 In patients with neurogenic orthostatic hypotension (NOH), the availability of the s

52 Initial orthostatic hypotension occurred in 32.9% (95% CI, 31.2%

53 Orthostatic hypotension occurs in more than half of frai

54 Patients with Parkinson's disease (PD) and orthostatic hypotension (OH) (PD+OH) or with pure autono

55 arkinsonism and non-motor features including orthostatic hypotension (OH) and cognitive impairment.

56 An association between orthostatic hypotension (OH) and mortality has been repo

57 Four orthostatic hypotension (OH) groups were defined based o

58 Orthostatic hypotension (OH) is a common cardiovascular

59 Orthostatic hypotension (OH) is a common cause of transi

60 Orthostatic hypotension (OH) is a fall in blood pressure

61 Orthostatic hypotension (OH) is common in elderly people

62 sed on HUT results, we divided patients into orthostatic hypotension (OH), postural tachycardia syndr

63 n the heart and other organs, manifesting as orthostatic hypotension (OH; also known as postural hypo

64 available concerning the predictive value of orthostatic hypotension on mortality in ambulatory elder

65 Patients with orthostatic hypotension or absent sympathetic skin respo

66 No crew member exhibited orthostatic hypotension or presyncopal symptoms during t

67 cterised by autonomic failure, manifested as orthostatic hypotension or urogenital dysfunction, with

68 A total of 171 patients with orthostatic hypotension participated in a multicenter, r

69 measured in patients with PD with or without orthostatic hypotension (PD+OH, PD-No-OH); in patients w

70 Whereas neurogenic orthostatic hypotension poses risks for falls and can be

71 or autonomic failure in Parkinson disease), orthostatic hypotension reflects sympathetic neurocircul

72 uncomplicated faint, situational syncope, or orthostatic hypotension should receive electrocardiograp

73 n, upper gastrointestinal tract dysfunction, orthostatic hypotension, sweating abnormalities, or erec

74 gene encoding alpha-synuclein, also features orthostatic hypotension, sympathetic neurocirculatory fa

75 apeutic requirements for managing neurogenic orthostatic hypotension that manifests with falls or cog

76 supine hypertension when treating neurogenic orthostatic hypotension; the effectiveness of nocturnal

77 e symptomatic autonomic failure (symptomatic orthostatic hypotension, urinary incontinence, or both)

78 There was no effect by center, severity of orthostatic hypotension, use of fludrocortisone or compr

79 sk factors were identified across 6 domains: orthostatic hypotension, visual impairment, impairment o

80 The prevalence of orthostatic hypotension was 6.9% (95% CI, 5.9%-7.8%) in

81 Overall prevalence of orthostatic hypotension was 6.9% and increased with age.

82 t stroke, coronary heart disease and cancer, orthostatic hypotension was a significant independent pr

83 Program's fourth examination (1991 to 1993), orthostatic hypotension was assessed in relation to subs

84 Orthostatic hypotension was defined as a drop in systoli

85 Orthostatic hypotension was most prevalent before breakf

86 ed mortality rates in those with and without orthostatic hypotension were 56.6 and 38.6 per 1000 pers

87 ous events, two of which (hallucinations and orthostatic hypotension) were deemed related to study dr

88 ay contribute to the increased prevalence of orthostatic hypotension with age.